Renaissance Technologies’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

Renaissance Technologies’s Portfolio TBIO Stock Details TBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-22,300	Closed	-$614K	–	4022
2021 Q2	$614K	Buy	+22,300	New	+$438K	﹤0.01%	2881
2019 Q3	–	Sell	-34,000	Closed	-$429K	–	3830
2019 Q2	$429K	Buy	+34,000	New	+$358K	﹤0.01%	3058

Renaissance Technologies's TBIO Position: Q3 2021 in Review

Renaissance Technologies sold out of Translate Bio, Inc. Common Stock (TBIO) in Q3 2021, closing a stake of 22,300 shares — an estimated $614K sold.

Renaissance Technologies first reported a position in TBIO in Q2 2019 and held it in 2 quarters. The position peaked at $614K in Q2 2021. 0 funds tracked by Wall St. Rank hold TBIO as of Q3 2021.

Renaissance Technologies reported no remaining Translate Bio, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
Renaissance Technologies sold 22,300 Translate Bio, Inc. Common Stock shares in Q3 2021, an estimated $614K.
Renaissance Technologies first reported a position in Translate Bio, Inc. Common Stock in Q2 2019 and held it in 2 quarters.
Renaissance Technologies's Translate Bio, Inc. Common Stock position peaked at $614K in Q2 2021.
0 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q3 2021.

Based on Renaissance Technologies's 13F filing for Q3 2021, filed 12 Nov 2021.